Charity number: 1160013
MSTART (MEDICAL AND SPORTING TECHNOLOGY RESEARCH TRUST)
UNAUDITED
TRUSTEES, REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

MSTART (MEDICAL AND SPORTING TECHNOLOGY RESEARCH TRUST)
CONTENTS
Page
Reference and admSnlstratlve detalls of the charlty, Its trustees and advlser8
Trusteas. report
Statement of flnancial actlvltles
Balance sheet
Noteg to the flnanclal slatements
6-12

MSTART (MEDICAL AND SPORTING TECHNOLOGY RESEARCH TRUST)
REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS
FOR THE YEAR ENDED 31 MARCH 2025
Trustees
A Delve, Trustee
M Morris, Chairman
H Croft, Trustee
C Morris. Trustee
Charlty reglstered number
1180013
Page 1

MSTART (MEDICAL AND SPORTING TECHNOLOGY RESEARCH TRUST)
TRUSTEES. REPORT
FOR THE YEAR ENDED 31 MARCH 2025
The Trustees present their annual report together with the financial statements of the charity for the year 1 April
2024 to 31 March 2025.
Objectlves and Actlvltles
Pollcle8 and obJectlves
In setting objectives and planning for activities, the Trustees have given due consideration to general guidance
published by the Charity Commission relating to public benefit and consider this criteria is rnet on the basis of
the charily's primary charilable objectives. These being:
The promotion of health and saving lives by sponsorship of research and development in medical technology.
The advancement in the Ilves of young people and thelr education, p8rtlcularly In science and technology. in
order to develop their skills. capacities and capabilitles to enable them lo participate in society as mature and
responsible individuals.
The promotion of amateur sport for the purposes of healthy recreation.
The charity's main objectives in the year have been to raise funds and to identlfy groups, organisations and
Individuals to asslst In accordance with the primary objectives above.
b. Actlvltl•$ for achl•vlng obJ•ctI￿9
Durlng the year to 31 st March 2025 the charity has identified and assisted a number of groups, organisallons
and individuals by way of grants and donations.
A¢hlov•monts and performanco
a. R•viow of activiti•s
In the year to 31 st March 2025 total donations and grants in excess of £226,000 have been made. Donations
have been made to individuals to assist them to pursue advanced medical treatments not available on the
NHS. and to young sporting lalents to assist them at the early stages of their careers.
Flnanclal rnvlew
a. Golng concern
After making appropriate enquiries, the truste88 have a reasonable expectation that the charity has adequale
resources to continue in operalional existence for the foreseeable future. For thls reason Ihey continue to adopt
the going concern basis in preparing the financial statements. Further details regarding the adoption of the
going concern basis can be found in the Accounting Policies.
Structure, governance and management
a. Constltutlon
The principal object of the charlty is to provide funding for projects designed for the advancement of health or
saving lives through sponsoring research in this area,. the promotion of amateur sporting activities and the
involvement of young people In such activities.
b. Method of appolnlment or election of Trustees
The management of the charity is the responsibility of Iha Trustees who are elected and co-opled under the
terms of the Trust deed.
Page 2

MSTART (MEDICAL AND SPORTING TECHNOLOGY RESEARCH TRUST)
TRUSTEES, REPORT (continued>
FOR THE YEAR ENDED 31 MARCH 2025
c. Organlsatlonal structuro and declslon maklng
The Trustees make all the decisions regarding all matters relevant lo the Trust.
This report was approved by the Trustees, on 2w/812025
and slgned on their behalf by..
M Morri8, Chaimian
Trustee
Page 3

MSTART (MEDICAL AND SPORTING TECHNOLOGY RESEARCH TRUST)
STATEMENT OF FINANCIAL ACTIVITIES
FOR THE YEAR ENDED 31 MARCH 2025
Unrestricted
funds
2025
Total
funds
2025
Total
funds
2024
Noto
Income from:
Investments
Total Income
Expèndituré on:
Charitable activities
Total expendlture
308
Net Income l (expendlture) before othor rocognised galn8
and1088e8
1253,820) (253,820)
(137,0051
Net movemont In funds
1253,820) (253,820)
(137,0051
Reconclllatlon of fund8:
Total funds brought forward
8 176 253 253 ￿LI
Total fund8 carrlad fonmard
The notes on pages 6 to 12 form part of these financial slatemenls.
Page 4

MSTART (MEDICAL AND SPORTING TECHNOLOGY RESEARCH TRUST)
BALANCE SHEET
AS AT 31 MARCH 2025
2025
2024
Note
Fixed as8¢ts
Investments
600,001
600,001
Current assets
Debtors
669,931
669.931
Cash at bank and in hand
6 655 501
6 908 722
7,325,432
7,578,653
Credltors: amounts falllng due within one
year
Not current asset8
7 322 432
7 576 252
Not assets
Charlty Fund•
Unrestrlcted funds
7 922 433
8 176253
Total funds
The financial statements were approved by the Trustees on £k)15/2' D25 and sl9ned on their behalf, by:
M Morrls,
alrman
The notes on pages 6 to 12 form part of these financial statements.
Page 5

MSTART (MEDICAL AND SPORTING TECHNOLOGY RESEARCH TRUST
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
Accountlng pollGles
1.1 8a31s of preparatlon of flnanGlal statements
The financial statements have been prepared in accordance with the Charilies SORP {FRS
102) Accounting and Reporting by Charities: Statement of Recommended Practice applicable lo
charities preparing their accounts in accordanc8 Wlth the Financial Reporting Standard applicable in
the UK and Republic of Ireland (FRS 102) (effective 1 January 2015). the Flnanclal Reporting
Standard applicab18 in the UK and Republic of Ireland (FRS 102).
MSTART (Medical and Sporting Technology Research Trust) constitutes a public benefit entity as
defined by FRS 102. Assets and liabilities are initially recognised at historical cost or transaction
value unless otherwise stated the relevant accounting policy.
The financial statements are prepare(l in sterling (£) which is Ihe functional currency of the charity.
The significant accountlng pollcies that have been applied in the preparation of these financial
statements are set out below. These pollcies have been consisteniiy applied to all years presented
unless otherwlse stated.
1.2 Income
All income Is reco9nised once the charity has entitlèment to the Sncome, it Is probable that the
Income wlll be recelved and the amount of Income recelvable can be measured rellably.
Income tax recoverable In relatlon to donatlons received under Glft Ald or deeds of covenanl is
recognlsed at the tlme of the donation.
Income lax recoverable in relalion to investment income Is recognised at the time the investment
income is receivable.
1.3 Expendltur•
Expendoture 18 recognised once there is a legal or constructive obligation to transfer economic
beneflt to a third party, il is probable thal a transfer of economic benefits will be required in
settlement and Ihe amount of the obligation can be measured reliably. Expenditure is classified by
aclivity. The costs of each activity are made up of the total of direct costs and shared costs,
Including support cosls involved in undertaking each activity. Direct costs attributable to a single
aclivity are allocated direclly to that acllvity. Shared costs whlch contrlbute to more than one activity
and support costs which are not attribulable to a slngle actlvily are apportloned between those
aclivities on a basis consistent with the use of resources. Central staff costs are allocated on the
basis of time spent, and depreclation charges allocated on the portion of the assel's use.
Support costs are those cosls incurred directly in support of expenditure on the objects of the
charity aT)d include project management carried out at Headquarters.
Charitable activities and Governance costs are costs incurred on Ihe charity's operations, including
support costs and costs relating to the governance of the charity apportioned to charltable activlties.
Page 6

MSTART (MEDICAL AND SPORTING TECHNOLOGY RESEARCH TRUST)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
Accountlng policies (contlnued)
1.4 Investm8nt8
Fixed asset investmenls are a form of financial instrument and are initially recognised at their
transaclion cost and subsequently measured at fair value at the Balance sheet date. unless fair
value cannot be measured reliably in which case it is measured at cost less impairment. Investment
gains and losses, whether realised or unrealised. are combined and shown in the heading
'Gainsl(losses) on investrnents. in the Statement of financial activities.
1.5 Interest re¢¢lvable
Interest on funds held on deposit is included when receivable and the amount can be measured
reliably by the charity,, this is normally upon notification of the interesl paid or payable by the Bank.
1.6 Debtorg
Trade and other debtors are recognisad at the settlemenl amount after any trade discount offered.
Prepayments are valued at the amount prepald nel of any trade discounts due.
1.7 Cash at Bank and In hand
Cash at bank and in hand includes cash and short term highly liquid investmenls with a short
maturity of three months or less from the date of acquisition or opening of the deposlt or slmllar
account.
1.8 Llabllltlas and provl8lons
Llabllities are recognised when there is an obligation at the 8alance Sheet date as a result of a past
evenl, it is probable that a transfer of economic benefil will be required in settlement, and the
amount of the settlement can be estimated reliably. Liabilrties are recognised al the amount that the
charity anticlpates it will pay to settle the debt or Ihe amount it has received as advance(I payments
for the goods or services il must provide. Provisions are measure<l at the best estimate of the
amounts required to settle the obligation. Where the effect of the time value of money Is materlal,
the provision is based on the present value of those amounts. dlscounted at the pre-tax discount
rate that reflects the risks speclfic lo the liability. The unwinding of the discount is r8cognised wlthln
interest payable and simllar charges.
1.9 Flnancial Instruments
The charity only has financial assels and financlal Ilabllllles of a kind that qualify as basic financial
Instruments. Basic financial instruments are Initlally recognised at transaction value and
subsequently measured at their selllement value wlth the exception of bank loans which are
subsequenlly measured at amortised cost uslng the effective Interest method,
1.10 Penslons
The charity operates a defined contribution pension scheme and the penslon charge represents the
amounts payable by the charity to the fund in respect of the year.
1.11 Fund accountlng
General funds are unrestricted fund5 which are available for use at the discretion of the Truslees in
furtherance of the general objectives of the charity and which have not been designated for other
purposes.
Page 7

MSTART (MEDICAL AND SPORTING TECHNOLOGY RESEARCH TRUST)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
Investment Income
Unrestrlcted
funds
2025
Total
funds
2025
Total
funds
2024
Charity inv inc - interest
Total 2024
Dlroct cost8
Communlty
grants
Total
2025
Total
2024
Grants awarded
Total 2024
Support CO8t8
Total
2025
Total
2024
Other
Support
Premises costs
Accountancy fees
Insurance
Bank charges
Travelling
Compulers and software
Penalties and flnes
Wages and salaries
Pension cost
21,600
7,800
21,600
7,800
21,600
2,180
735
122
42
888
103
103
43
(3,295)
{3.2951
11,370
753
Subtotal
26.852
26,852
37,6￿)
Rounding
Total 2024
During the year ended 31 March 2025. the charity incurred the followlng Governance costs:
Page 8

MSTART (MEDICAL AND SPORTING TECHNOLOGY RESEARCH TRUST)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
Staff cost6
Staff costs were as follows:
2025
2024
Wages and salaries
Other pension costs
(3,295)
11.370
753
The average number of persons employed by the charity during the year was as follows..
2025
No.
2024
No.
No employee received remuneration amounting to more than £60,000 In elther yéar,
Flxed asset Invastment8
Shares In
group
undertaklngs
Market value
At 1 Aprll 2024 and 31 March 2025
Subsldlary und•rtaklngs
The following were subsidiary undertakings of the company:
Name
Holdlng
ITREND Medical Research Limiled
750/.
New Park Place Limited
100%
The aggregate of the share capital and reserve5 as at 31 March 2025 and of the profit or loss for the
year ended on that date for the subsidiary undertakings were as follows..
Aggregate of
share capltal
and resorvos
Namo
Profitl{1088)
ITREND Medical Research Limited
New Park Place Limited
(478,237)
{6,195)
Page 9

MSTART (MEDICAL AND SPORTING TECHNOLOGY RESEARCH TRUSTI
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
Dèbtors
2025
2024
Amounts owed by group undertakings
Other debtors
Prepayments and accrued income
178,670
491,261
178,670
491,261
Credltors: Amount8 falllng due wlthln one year
2025
2024
Other laxation and social security
Accruals
3,000
2,401
Statement of funds
Statement of funds - ¢L•rrent year
Balance al
31 March
2025
Balan¢0 at
1 Aprll 2024
Incom• Expondlture
Unrestricted funds
General Funds
Statement of funds - prlor year
Balance at
31 March
2024
Balance at
1 April 2023
Income Expenditure
General funds
General Funds
Summary of funds - current year
Balan￿ at
31 March
2025
Balance at
1 Aprll 2024
Income Expendlturo
General funds
Page 10

MSTART IMEDICAL AND SPORTING TECHNOLOGY RESEARCH TRUST)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
Statemgnt of funds <Gontlnued)
Summary of funds- prlor year
Balance at
31 March
2024
Balance at
1 April 2023
Income Expenditure
General funds
10. Analys18 of net assets between fund8
Analysis of net a8sots between fund8 - current year
Unrestrlcted
funds
2025
Total
funds
2025
Fixed asset investments
Current assets
Creditors due within one year
600,001
7,325,432
(3,000)
600,001
7,325,432
(3,000)
Analygls of n•t assets botween funds - prlor year
Unrestricled
funds
2024
Total
funds
2024
Fixed asset investments
Current assels
Creilitors (lue within one year
600,001
7,578,653
(2,401)
600,001
7,578,653
(2.401)
11. Roconclllation of net movement In funds to net cash flow from operatlng actlvltles
2025
2024
Nel (expenditure)lincome for the year (as per Statement of Financlal
Activities)
(253,820)
(137,005)
Adjustment for:
Decreasel(increase) in debtors
Increasel(decrease) In creditors
3,524,589
Net cash provlded by operatlng activities
Page11

MSTART IMEDICAL AND SPORTING TECHNOLOGY RESEARCH TRUST)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
12. Analysls of cash and cash equlvalents
2025
2024
Cash In hand
6 655 501
6 908 722
Total
13. Pènslon ¢ommltm•nts
The charity operates a defined coniributions pension scheme. The assets of the scheme are held
separately from those of the charlly in an independently administered fund. The pension Cost charge
represents contributions payable by the charity to Ihe fund and amounted to (£3,295) (2024: £753).
There are no outstanding contributions as at the balance sheet date.
14. R•lat•d party transactlons
During the year, no Trustees received any remuneration.
During the year, no Trustees received any benefits in kind.
During the year, no Trustees received any reimbursemenl of expenses.
Page 12